Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison

AIM: To conduct an adjusted indirect treatment comparison (aITC) of the efficacy of tirzepatide 5/10/15 mg versus semaglutide 2 mg in patients with type 2 diabetes. MATERIALS AND METHODS: The primary analysis was a Bucher aITC of the change from baseline at week 40 in HbA1c (%) and body weight (kg)....

Descripción completa

Detalles Bibliográficos
Autores principales: Vadher, Karan, Patel, Hiren, Mody, Reema, Levine, Joshua A., Hoog, Meredith, Cheng, Alice YY., Pantalone, Kevin M., Sapin, Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546430/
https://www.ncbi.nlm.nih.gov/pubmed/35589616
http://dx.doi.org/10.1111/dom.14775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546430/
https://www.ncbi.nlm.nih.gov/pubmed/35589616
http://dx.doi.org/10.1111/dom.14775

Ejemplares similares